Description
Cagrilintide is a synthetic long-acting amylin analog research peptide. It is a modified 37-amino-acid compound featuring amino acid substitutions, C-terminal amidation, and a fatty-acid side chain, supplied as a high-purity lyophilized powder for laboratory use only.
Reported specifications commonly include a molecular weight of approximately 4409 g/mol and a molecular formula of C₁₉₄H₃₁₂N₅₄O₅₉S₂, with a disulfide bond in the N-terminal region. Identity and purity are confirmed by HPLC and mass spectrometry.
In laboratory and preclinical research, cagrilintide has been investigated for effects on amylin and calcitonin receptor signaling, including studies related to satiety pathways, energy-balance models, and metabolic regulation in experimental systems. These findings are limited to research settings and do not establish approved medical use.
This material is not approved for human or veterinary use and is not intended for consumption.
Reviews
There are no reviews yet.